Literature DB >> 15565259

Prevalence of mycobacteremia in patients with AIDS and persistant fever.

Hélio Arthur Bacha1, Sérgio Cimerman, Simone A de Souza, David Jamil Hadad, Caio Márcio Figueiredo Mendes.   

Abstract

In the advanced stages of AIDS, characterized by severe immunodepression, tuberculosis (TB) may present with a clinical picture of septic shock, due to typical bacteremia. Hematogenic dissemination of mycobacteria is frequent in immunodepressed patients with TB or disseminated mycobacteriosis, leading to increased positivity in detection by automated blood culture. The objective of our study was to determine the prevalence of mycobacteremia in patients with AIDS and with prolonged fever seen at the Emilio Ribas Institute of Infectology. Patients with a history of daily fever (> or = 37.8 degrees C), lasting more than 30 days, and with CD4+ helper lymphocyte counts below 200 cells/mL, were selected from February 2001 to March 2002. A 5 mL peripheral blood sample was collected from each patient for mycobacterial blood culture by an automated method, using the BACTEC 9000 MB and MB/BACT techniques. Forty-five patients aged on average 35 years, most of them males, were included in the study. The mean T CD4+ lymphocyte count was 58 cells/mL. Among the samples submitted to blood culture, 30% gave M. tuberculosis growth, with 62% sensitivity. Among the patients with a negative blood culture, nine had received a diagnosis of TB by another method. Automated blood culture proved to be a technique of relevant diagnostic value for M. tuberculosis in patients with prolonged fever in advanced stages of AIDS. The method is simple, and it helps the physician to select the best therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565259     DOI: 10.1590/s1413-86702004000400004

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  7 in total

Review 1.  Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis.

Authors:  P B Pavlinac; E M Lokken; J L Walson; B A Richardson; J A Crump; G C John-Stewart
Journal:  Int J Tuberc Lung Dis       Date:  2016-07       Impact factor: 2.373

2.  Assessment of mycobacteremia detection as a complementary method for the diagnosis of tuberculosis in HIV-infected patients.

Authors:  J Hernández; A Jaramillo; G I Mejía; P Barón; V Gomez; M A Restrepo; J Robledo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-24       Impact factor: 3.267

3.  Mycobacterium tuberculosis Bacteremia Among Acutely Febrile Children in Western Kenya.

Authors:  Patricia B Pavlinac; Jaqueline M Naulikha; Grace C John-Stewart; Frankline M Onchiri; Albert O Okumu; Ruth R Sitati; Lisa M Cranmer; Erica M Lokken; Benson O Singa; Judd L Walson
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

4.  Novel method for clearing red blood cell debris from BacT/ALERT blood culture medium for improved microscopic and antimycobacterial drug susceptibility test results.

Authors:  Krishnamoorthy Gopinath; Sandeep Kumar; Manimuthu Mani Sankar; Sarman Singh
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

5.  Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture system.

Authors:  K Gopinath; S Kumar; S Singh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-10       Impact factor: 3.267

6.  Comparative radiological features of disseminated disease due to Mycobacterium tuberculosis vs non-tuberculosis mycobacteria among AIDS patients in Brazil.

Authors:  Rodrigo P dos Santos; Karin L Scheid; Denise Mc Willers; Luciano Z Goldani
Journal:  BMC Infect Dis       Date:  2008-02-29       Impact factor: 3.090

7.  Mycobacterium tuberculosis complex bacteremia among HIV and non-HIV patients in a Mexican tertiary care center.

Authors:  Karla Maria Tamez-Torres; Pedro Torres-Gonzalez; Miguel E Cervera-Hernandez; Barbara Chavez-Mazari; Corazon de Jesus Barrientos-Flores; Miriam Bobadilla-Del-Valle; Alfredo Ponce-de-Leon; Jose Sifuentes-Osornio
Journal:  Braz J Infect Dis       Date:  2018-10-30       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.